E

Excel Industries Ltd

Q3 FY25Chemicals & Petrochemicals

Excel Industries Ltd Q3 FY25 Results & Presentation Highlights: Revenue ₹196 Cr, PAT ₹6 Cr

Q3 FY25 investor presentation: what the company reported on revenue, margins and projects.

Price₹950
Market cap₹1.2K Cr
P/E16.9
Updated24 Sept 2026
Read4 min read

Based on Excel Industries Ltd's Q3 FY25 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.

The short version

Q3 FY25 revenue: ₹196 crore, a 27% decline from Q2 FY25 (Page 5, 6). Q3 FY25 EBITDA: ₹12 Cr, down 75% YoY - Q3 FY25 Operating Margin (EBITDA Margin): 6.3%, declined from 18.3% in Q3 FY24 - Q3 FY25 Profit After Tax (PAT): ₹6 Cr, down 81% YoY - Q3 FY25 PAT Margin: 3.3%, declined from 12.7% in Q3 FY24 - The presentation notes the decline in margins was due to lower volume and increased key input material costs.

From Excel Industries Ltd's Q3 FY25 earnings-call transcript · updated 24 Sept 2026.

Revenue & Sales Performance

  • Q3 FY25 revenue: ₹196 crore, a 27% decline from Q2 FY25 (Page 5, 6).
  • Year-on-year (Y-o-Y) revenue growth for 9MFY25: ₹730 crore, a 23% increase from 9MFY24 ₹593 crore (Pages 7, 8).
  • Q3 FY25 exports revenue was 21% of total revenue (Page 5).
  • Revenue decline in Q3 FY25 attributed to lower demand due to agro market inventory destocking and reduction in key product sales prices (Page 5).
  • No explicit future outlook on revenue or volume projections is provided in the presentation.

2 more points management made on revenue & sales performance

Profitability & Margins

See what Excel Industries Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Executed Rs 346 Cr Capex over 2019–24, including acquisition of Visakhapatnam site.
  • Upgraded wastewater treatment capabilities at Lote and Roha sites.
  • Received Environmental Clearances for expanding production capacities and product offerings at Lote (2020) and Roha (2021).
  • Introduced new product capacities: Sodium Trichloro Pyridinol (NaTCP), DMPAT, polymer additive.
  • Added volume capabilities for existing and new products like Phosphorus Pentasulphide, Diethyldithiophosphoryl Chloride, Diazotization Chemistry platform, Phosphonates, and Pharma intermediates.
  • Set-up of a new PCL3 (Phosphorus Trichloride) plant at Lote in 2023.

2 more points management made on capital expenditure plans

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

5x potential
Rev 1Mar 2
2Yasho Industries
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Excel Industries Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The investor presentation does not explicitly mention or report any details on order book, order inflow, or pending orders. - There are no specific figures or statements related to order book or pending orders in the provided pages. - The presentation focuses mainly on financial performance, shareholder returns, historical performance, sustainability pillars, leadership, and contact details. - Revenue, EBITDA, PAT, margins, and operational metrics are discussed, but order-related metrics are not disclosed. Thus, based strictly on this presentation's content, no information on order book, order inflow, or pending orders is provided.

Excel Industries Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹281 Cr, net profit ₹12 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Himadri Speciality Chemical Ltd (Q3 FY25)

    1,131.81 Crs, up 7.53% YoY (from Rs. Key investor presentation takeaways from Himadri Speciality Chemical Ltd's Q3 FY25 investor presentation — and how it ranks

  • Gujarat Alkalies & Chemicals Ltd (Q3 FY25)

    3,702.77 Crores (up from Rs. Key investor presentation takeaways from Gujarat Alkalies & Chemicals Ltd's Q3 FY25 investor presentation — and how it ranks agains

  • Balaji Amines Ltd (Q3 FY25)

    Q3FY25 consolidated revenue from operations was ₹321 crore, down 18% YoY from ₹392 crore in Q3FY24 (Page 7). Key investor presentation takeaways from Balaji Ami

  • Vidhi Specialty Food Ingredients Ltd (Q3 FY25)

    Year-on-Year (Y-o-Y) Growth:** 56.5% increase . Key investor presentation takeaways from Vidhi Specialty Food Ingredients Ltd's Q3 FY25 investor presentation —

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Excel Industries Ltd Q3 FY25 results?

Q3 FY25 revenue: ₹196 crore, a 27% decline from Q2 FY25 (Page 5, 6). Q3 FY25 EBITDA: ₹12 Cr, down 75% YoY - Q3 FY25 Operating Margin (EBITDA Margin): 6.3%, declined from 18.3% in Q3 FY24 - Q3 FY25 Profit After Tax (PAT): ₹6 Cr, down 81% YoY - Q3 FY25 PAT Margin: 3.3%, declined from 12.7% in Q3 FY24 - The presentation notes the decline in margins was due to lower volume and increased key input material costs.

What is Excel Industries Ltd share price analysis?

Excel Industries Ltd currently shows a neutral. The stock trades at a P/E of 16.9 with a market cap of ₹1,205 Cr. Investors should review the full earnings analysis for detailed insights.

Is Excel Industries Ltd planning capital expenditure?

Executed Rs 346 Cr Capex over 2019–24, including acquisition of Visakhapatnam site.

Keep Excel Industries Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.